REFERENCES


Gene Name Gene ID Pubmed ID Classification Mechanism Marker Type Normal Cases Disease Cases Age Mean Age Place FIGO Grade Remark Title Journal Volume Year
IGF13479 9279518Endometrial adenocarcinoma + Endometrial adenosquamous  Up regulation/ Over expression/High expression  -  -  27  23 (22 endometrial adenocarcinoma + 1 endometrial adenosquamous); 11 (uterine cervical cancer)  30 to 74 (diseased); 22 to 75 (control)  -  Japan  I (n=11); II (n=3); III (n=9)  1 (n=10); 2 (n=10); 3 (n=3)   Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer  Endocrine Journal  44(3):419-24  1997  
IGF13479 15066926-  -  -  -  136  174  -  -  Chicago (Northwestern University); IL; Chicago (Rush Medical College); IL; Hershey; PA; Irvine; CA; Long Beach; CA; Minneapolis; MN; and Winston-Salem; NC  -  -   Insulin-like growth factors; insulin-like growth factor-binding proteins; and endometrial cancer in postmenopausal women: results from a U.S. case-control study  Cancer epidemiology; biomarkers & prevention  13(4):607-12  2004  
IGF13479 18006148-  Down regulation/ Down expression  -  -  30  30  31 to 88  64.8  Department of Obstetrics and Gynecology; PAGNH University Hospital Crete.  I (n=14); II (n=12); III (n=4)  1 (n=6); 2 (n=17); 1-2 (n=2); 3 (n=5)   FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.  Cancer Letters  259(2):146-55  2008